Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 7, 2005; 11(33): 5156-5161
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5156
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5156
Figure 2 Cytotoxicity of amygdalin.
SNU-C4 human colon cancer cells were treated with various concentrations (0.25, 0.5, 2.5, and 5 mg/mL) of amygdalin for 24 h prior to the determination of cellular viability through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Independent experiment was repeated thrice. Results are presented as mean±SE (bP<0.01 vs control group).
- Citation: Park HJ, Yoon SH, Han LS, Zheng LT, Jung KH, Uhm YK, Lee JH, Jeong JS, Joo WS, Yim SV, Chung JH, Hong SP. Amygdalin inhibits genes related to cell cycle in SNU-C4 human colon cancer cells. World J Gastroenterol 2005; 11(33): 5156-5161
- URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5156.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5156